MeCour Temperature Control is a global manufacturing company founded in 1999 that specializes in providing precise, uniform, and stable thermal management systems for laboratory applications. The company's products cater to various industries, including biological assays, drug screening, genomics, compound management, and storage. These thermal control systems cover an extensive temperature range from -100°C to +300°C, accommodating a wide array of consumables such as plates, tubes, reagent, and media reservoirs. Renowned pharmaceutical and biotech companies rely on MeCour's solutions to enhance their laboratory productivity and prevent wastage. By offering alternatives to traditional methods such as thermal electric devices, hot plates, dry ice, and freezers, MeCour ensures sample integrity and accurate results. The company is based in the United States and provides versatile thermal control systems, ranging from benchtop units to SBS compliant and custom-designed solutions for automation. Moreover, MeCour guarantees seamless integration with all automated platforms. As of now, there is no publicly disclosed information regarding the latest investment or involved investors. To leverage MeCour's expertise in thermal control solutions and design a tailored application, interested parties can directly engage with the company. Evidently, MeCour Temperature Control stands as a reliable and innovative industry player, catering to the evolving needs of laboratory thermal management.
There is no investment information
No recent news or press coverage available for MeCour Temperature Control.